Smart Pills Market Research Report Information By Application (Patient Monitoring and Others), By Target Area (Esophagus, Small Intestine and Others), By Disease Indication (Disease Indication and Others), By End User (Hospitals and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Smart Pills Market, by Application

6.1 Introduction

6.2 Capsule Endoscopy

6.2.1 Small Bowel Capsule Endoscopy

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Controllable Capsule Endoscopy

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.3 Colon Capsule Endoscopy

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Drug Delivery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Patient Monitoring

6.4.1 Capsule pH monitoring

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4.2 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Other Applications

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 7. Global Smart Pills Market, by Target Area

7.1 Introduction

7.2 Esophagus

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Small Intestine

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Large Intestine

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.5 Stomach

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Smart Pills Market, by Disease Indication

8.1 Introduction

8.2 Esophageal Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Small Bowel Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Colon Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Smart Pills Market, by End-User

9.1 Introduction

9.2 Hospital

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Diagnostic Center

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Research Institute

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 10. Global Smart Pills Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Olympus Corporation

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Proteus Digital Health, Inc.

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 CapsoVision, Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 MEDTRONIC

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 FUJIFILM Holdings Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 RF Co., Ltd.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Check-Cap

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 BDD Limited

12.8.1 Overview

12.8.2 Product/Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 JINSHAN Science & Technology

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 MEDISAFE

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 PENTAX Medical

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 INTROMEDIC

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Smart Pills Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Smart Pills Market Synopsis, 2018–2023

Table 2 Global Smart Pills Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Smart Pills Market, by Region, 2018–2023 (USD Million)

Table 4 Global Smart Pills Market, by Application, 2018–2023 (USD Million)

Table 5 Global Smart Pills Market, by Target Area, 2018–2023 (USD Million)

Table 6 Global Smart Pills Market, by Disease Indication, 2018–2023 (USD Million)

Table 7 Global Smart Pills Market, by End-User, 2018–2023 (USD Million)

Table 8 North America: Smart Pills Market, by Application, 2018–2023 (USD

Million)

Table 9 North America: Smart Pills Market, by Target Area, 2018–2023 (USD

Million)

Table 10 North America: Smart Pills Market, by Disease Indication, 2018–2023 (USD

Million)

Table 11 North America: Smart Pills Market, by End-User, 2018–2023 (USD

Million)

Table 12 US: Smart Pills Market, by Application, 2018–2023 (USD Million)

Table 13 US: Smart Pills Market, by Target Area, 2018–2023 (USD Million)

Table 14 US: Smart Pills Market, by Disease Indication, 2018–2023 (USD Million)

Table 15 US: Smart Pills Market, by End-User, 2018–2023 (USD Million)

Table 16 Canada: Smart Pills Market, by Application, 2018–2023 (USD Million)

Table 17 Canada: Smart Pills Market, by Target Area, 2018–2023 (USD Million)

Table 18 Canada: Smart Pills Market, by Disease Indication 2018–2023 (USD

Million)

Table 19 Canada: Smart Pills Market, by End-User, 2018–2023 (USD

Million)

Table 20 South America: Smart Pills Market, by Application, 2018–2023 (USD

Million)

Table 21 South America: Smart Pills Market, by Target Area, 2018–2023 (USD

Million)

Table 22 South America: Smart Pills Market, by Disease Indication, 2018–2023 (USD

Million)

Table 23 South America: Smart Pills Market, by End-User, 2018–2023 (USD

Million)

Table 24 Europe: Smart Pills Market, by Application, 2018–2023 (USD Million)

Table 25 Europe: Smart Pills Market, by Target Area, 2018–2023 (USD Million)

Table 26 Europe: Smart Pills Market, by Disease Indication, 2018–2023 (USD Million)

Table 27 Europe: Smart Pills Market, by End-User, 2018–2023 (USD Million)

Table 28 Western Europe: Smart Pills Market, by Application, 2018–2023 (USD

Million)

Table 29 Western Europe: Smart Pills Market, by Target Area, 2018–2023 (USD

Million)

Table 30 Western Europe: Smart Pills Market, by Disease Indication, 2018–2023

(USD Million)

Table 31 Western Europe: Smart Pills Market, by End-User, 2018–2023

(USD Million)

Table 32 Eastern Europe: Smart Pills Market, by Application, 2018–2023 (USD

Million)

Table 33 Eastern Europe: Smart Pills Market, by Target Area, 2018–2023 (USD

Million)

Table 34 Eastern Europe: Smart Pills Market, by Disease Indication, 2018–2023

(USD Million)

Table 35 Eastern Europe: Smart Pills Market, by End-User, 2018–2023

(USD Million)

Table 36 Asia-Pacific: Smart Pills Market, by Application, 2018–2023 (USD

Million)

Table 37 Asia-Pacific: Smart Pills Market, by Target Area, 2018–2023 (USD

Million)

Table 38 Asia-Pacific: Smart Pills Market, by Disease Indication, 2018–2023 (USD

Million)

Table 39 Asia-Pacific: Smart Pills Market, by End-User, 2018–2023 (USD

Million)

Table 40 Middle East & Africa: Smart Pills Market, by Application, 2018–2023

(USD Million)

Table 41 Middle East & Africa: Smart Pills Market, by Target Area, 2018–2023

(USD Million)

Table 42 Middle East & Africa: Smart Pills Market, by Disease Indication, 2018–2023

(USD Million)

Table 43 Middle East & Africa: Smart Pills Market, by End-User, 2018–2023

(USD Million)
LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Smart Pills Market

Figure 3 Segmentation Market Dynamics for Global Smart Pills Market

Figure 4 Global Smart Pills Market Share, by Application, 2017

Figure 5 Global Smart Pills Market Share, by Target Area, 2017

Figure 6 Global Smart Pills Market Share, by Disease Indication, 2017

Figure 7 Global Smart Pills Market Share, by End-User, 2017

Figure 8 Global Smart Pills Market Share, by Region, 2017

Figure 9 North America: Smart Pills Market Share, by Country, 2017

Figure 10 Europe: Smart Pills Market Share, by Country, 2017

Figure 11 Asia-Pacific: Smart Pills Market Share, by Country, 2017

Figure 12 Middle East & Africa: Smart Pills Market Share, by Country, 2017

Figure 13 Global Smart Pills Market: Company Share Analysis, 2017 (%)

Figure 14 Olympus Corporation: Key Financials

Figure 15 Olympus Corporation: Segmental Revenue

Figure 16 Olympus Corporation: Geographical Revenue

Figure 17 Proteus Digital Health, Inc.: Key Financials

Figure 18 Proteus Digital Health, Inc.: Segmental Revenue

Figure 19 Proteus Digital Health, Inc.: Geographical Revenue

Figure 20 CapsoVision, Inc.: Key Financials

Figure 21 CapsoVision, Inc.: Segmental Revenue

Figure 22 CapsoVision, Inc.: Geographical Revenue

Figure 23 MEDTRONIC: Key Financials

Figure 24 MEDTRONIC: Segmental Revenue

Figure 25 MEDTRONIC: Geographical Revenue

Figure 26 FUJIFILM Holdings Corporation: Key Financials

Figure 27 FUJIFILM Holdings Corporation: Segmental Revenue

Figure 28 FUJIFILM Holdings Corporation. Geographical Revenue

Figure 29 RF Co., Ltd.: Key Financials

Figure 30 RF Co., Ltd.: Segmental Revenue

Figure 31 RF Co., Ltd.: Geographical Revenue

Figure 32 Check-Cap: Key Financials

Figure 33 Check-Cap: Segmental Revenue

Figure 34 Check-Cap: Geographical Revenue

Figure 35 BDD Limited: Key Financials

Figure 36 BDD Limited: Segmental Revenue

Figure 37 BDD Limited: Geographical Revenue

Figure 38 JINSHAN Science & Technology: Key Financials

Figure 39 JINSHAN Science & Technology: Segmental Revenue

Figure 40 JINSHAN Science & Technology: Geographical Revenue

Figure 41 MEDISAFE: Key Financials

Figure 42 MEDISAFE: Segmental Revenue

Figure 43 MEDISAFE: Geographical Revenue

Figure 44 PENTAX Medical: Key Financials

Figure 45 PENTAX Medical: Segmental Revenue

Figure 46 PENTAX Medical: Geographical Revenue

Figure 47 INTROMEDIC: Key Financials

Figure 48 INTROMEDIC: Segmental Revenue

Figure 49 INTROMEDIC: Geographical Revenue